DMBT1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DMBT1 monoclonal antibodies for research applications. DMBT1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DMBT1, or Deleted in Malignant Brain Tumors 1, is a protein that plays a crucial role in innate immunity and tissue homeostasis. DMBT1 is involved in the regulation of inflammation and has been implicated in various diseases, including cancer and neurodegenerative disorders. Understanding DMBT1 function is essential for elucidating its potential as a biomarker and therapeutic target. DMBT1 expression patterns can be effectively studied using specific detection methods across different tissue types. Researchers can utilize DMBT1 monoclonal antibodies to investigate cellular localization and protein interactions. DMBT1 monoclonal antibodies enable detailed analysis of molecular pathways in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular and molecular processes.